Relapse of Systemic Juvenile Idiopathic Arthritis after Influenza Vaccination in a Patient Receiving Tocilizumab-Reference-Cited by-同舟云学术

Relapse of Systemic Juvenile Idiopathic Arthritis after Influenza Vaccination in a Patient Receiving Tocilizumab

Published:2012-08-08 Issue:10 Volume:19 Page:1700-1702
ISSN:1556-6811
Container-title:Clinical and Vaccine Immunology
language:en
Short-container-title:Clin. Vaccine Immunol.

Author:

Shimizu Masaki,Ueno Kazuyuki,Yachie Akihiro

Abstract

ABSTRACTWe report the case of a patient with systemic juvenile idiopathic arthritis (s-JIA) receiving tocilizumab (TCZ) who experienced relapses of s-JIA after receiving influenza vaccination. Systemic symptoms of s-JIA might be masked during TCZ therapy. Careful observation with the monitoring of serum interleukin (IL)-18 and IL-6 levels may be useful.

Publisher

American Society for Microbiology

Subject

Microbiology (medical),Clinical Biochemistry,Immunology,Immunology and Allergy

Reference6 articles.

1. Glucocorticoid: major factor for reduced immunogenicity of 2009 influenza A (H1N1) vaccine in patients with juvenile autoimmune rheumatic disease;Aikawa;J. Rheumatol.,2012

2. Immunogenicity, safety and tolerability of MF59-adjuvanted seasonal influenza vaccine in children with juvenile idiopathic arthritis;Dell'Era;Vaccine,2012

3. Influenza immunization in children with chronic arthritis: a prospective study;Malleson;J. Rheumatol.,1993

4. Should children under treatment for juvenile idiopathic arthritis receive flu vaccination?;McCann;Arch. Dis. Child.,2007

5. Immunogenicity of influenza vaccine in children with pediatric rheumatic diseases receiving immunosuppressive agents;Ogimi;Pediatr. Infect. Dis. J.,2011

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy, Immunogenicity and Safety of Vaccination in Pediatric Patients With Autoimmune Inflammatory Rheumatic Diseases (pedAIIRD): A Systematic Literature Review for the 2021 Update of the EULAR/PRES Recommendations;Frontiers in Pediatrics;2022-07-06

2. EULAR/PRES recommendations for vaccination of paediatric patients with autoimmune inflammatory rheumatic diseases: update 2021;Annals of the Rheumatic Diseases;2022-06-20

3. Vaccinations in Children and Adolescents Treated With Immune-Modifying Biologics: Update and Current Developments;The Journal of Allergy and Clinical Immunology: In Practice;2022-06

4. Efficacy, immunogenicity, and safety of available vaccines in children on biologics: A systematic review and meta-analysis;Vaccine;2022-04

5. Two flares of Still’s disease after two doses of the ChAdOx1 vaccine;Clinical Rheumatology;2022-03-06